Accueil/Actions/ACONW

ACONW

USD

Aclarion Inc. Warrant

$0.033+0.002 (4.762%)

Prix en Temps Réel

Healthcare

Health Information Services

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$0.032

Haut

$0.033

Bas

$0.033

Volume

0.00M

Fondamentaux de l'Entreprise

Industrie

Health Information Services

Pays

United States

Statistiques de Trading

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.033Actuel $0.033Haut $0.033

Actualités Connexes

9heures · 10:00

GlobeNewswire

Aclarion Welcomes Advocate Health as CLARITY Trial Site

Advocate Health actively participates in research studies and is an innovator in technology, including spine The CLARITY trial is designed to demonstrate Nociscan's ability to improve surgical outcomes for chronic low

Aclarion Welcomes Advocate Health as CLARITY Trial Site

23 avr. 2025 · 10:00

GlobeNewswire

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

BROOMFIELD, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

21 avr. 2025 · 10:00

GlobeNewswire

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative DiscographyConclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10%